PKCα reduces the lipid kinase activity of the p110α/p85α PI3K through the phosphorylation of the catalytic subunit

被引:16
|
作者
Sipeki, S
Bander, E
Parker, PJ
Faragó, A
机构
[1] Semmelweis Univ, Dept Med Chem, Budapest, Hungary
[2] Canc Res UK, Prot Phosphorylat Lab, London, England
基金
匈牙利科学研究基金会;
关键词
PI3K; PKC; isoenzymes; isoenzyme-specific functions; signal transduction;
D O I
10.1016/j.bbrc.2005.10.194
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The modulation of phosphoinositide 3-kinase (PI3K) activity influences the quality Of Cellular responses triggered by various receptor tyrosine kinases. Protein kinase C (PKC) has been reported to phosphorylate signalling molecules upstream of PI3K and thereby it may affect the activation of PI3K. Here, we provide the first evidence for a direct effect of a PKC isoenzyme oil the activity of PI3K. PKC alpha but not PKC epsilon phosphorylated the catalytic subunit of the p110 alpha/p85 alpha PI3K in vitro in a manner inhibited by the PKC inhibitor bisindolylmaleimide I (BIM I). The incubation of PI3K with active PKC alpha resulted in a significant decrease in its lipid kinase activity and this effect was also attenuated by BIM I. We conclude that PKC alpha is able to modulate negatively the lipid kinase activity of the p110 alpha/p85 alpha PI3K through the phosphorylation of the catalytic Subunit. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:122 / 125
页数:4
相关论文
共 50 条
  • [1] Regulation of the p85/p110 phosphatidylinositol 3′-kinase:: Stabilization and inhibition of the p110α catalytic subunit by the p85 regulatory subunit
    Yu, JH
    Zhang, YT
    McIlroy, J
    Rordorf-Nikolic, T
    Orr, GA
    Backer, JM
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (03) : 1379 - 1387
  • [2] Regulation of the PI 3'-kinase catalytic subunit p110 by dimerization with the p85 regulatory subunit.
    Yu, JH
    McIlroy, J
    Wjasow, C
    Backer, JM
    [J]. DIABETES, 1997, 46 : 354 - 354
  • [3] Hot-spot mutations in p110α of phosphatidylinositol 3-kinase (PI3K) Differential interactions with the regulatory subunit p85 and with RAS
    Zhao, Li
    Vogt, Peter K.
    [J]. CELL CYCLE, 2010, 9 (03) : 596 - 600
  • [4] Oncogenic activity of the regulatory subunit p85β of phosphatidylinositol 3-kinase (PI3K)
    Ito, Yoshihiro
    Hart, Jonathan R.
    Ueno, Lynn
    Vogt, Peter K.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2014, 111 (47) : 16826 - 16829
  • [5] Cancer-derived mutations in the regulatory subunit p85α of phosphoinositide 3-kinase function through the catalytic subunit p110α
    Sun, Minghao
    Hillmann, Petra
    Hofmann, Bianca T.
    Hart, Jonathan R.
    Vogt, Peter K.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (35) : 15547 - 15552
  • [6] The structure of a human p110α/p85α complex elucidates the effects of oncogenic PI3Kα mutations
    Huang, Chuan-Hsiang
    Mandelker, Diana
    Schmidt-Kittler, Oleg
    Samuels, Yardena
    Velculescu, Victor E.
    Kinzler, Kenneth W.
    Vogelstein, Bert
    Gabelli, Sandra B.
    Amzel, L. Mario
    [J]. SCIENCE, 2007, 318 (5857) : 1744 - 1748
  • [7] PI3K activation is enhanced by FOXM1D binding to p110 and p85 subunits
    Wang, Qi
    Zhang, Pingzhao
    Zhang, Wei
    Zhang, Xin
    Chen, Jianfeng
    Ding, Peipei
    Li, Luying
    Lv, Xinyue
    Li, Ling
    Hu, Weiguo
    [J]. SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2020, 5 (01)
  • [8] PI3K activation is enhanced by FOXM1D binding to p110 and p85 subunits
    Qi Wang
    Pingzhao Zhang
    Wei Zhang
    Xin Zhang
    Jianfeng Chen
    Peipei Ding
    Luying Li
    Xinyue Lv
    Ling Li
    Weiguo Hu
    [J]. Signal Transduction and Targeted Therapy, 5
  • [9] p85 plays a critical role in controlling flux through the PI3K/PTEN signaling axis through dual regulation of both p110 (PI3K) and PTEN
    Anderson, Deborah H.
    [J]. CELL CYCLE, 2010, 9 (11) : 2055 - 2056
  • [10] p110 delta, a novel phosphatidylinositol 3-kinase catalytic subunit that associates with p85 and is expressed predominantly in leukocytes
    Chantry, D
    Vojtek, A
    Kashishian, A
    Holtzman, DA
    Wood, C
    Gray, PW
    Cooper, JA
    Hoekstra, MF
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (31) : 19236 - 19241